Company Overview of CellAct Pharma GmbH
CellAct Pharma GmbH, a biotechnology company, engages in the development of therapeutics for the treatment of cancers and inflammatory diseases. The company develops drug candidates that target and modulate human molecules which have specific functions in tumour growth and immune response; and antibodies against surface molecules in lymphocytes to treat cancer and inflammation. It focuses on developing drugs for various diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, transplant rejection, lymphomas, and leukemia. CellAct Pharma GmbH is based in Dortmund, Germany.
Key Executives for CellAct Pharma GmbH
Similar Private Companies By Industry
|Merck Serono GmbH||Europe|
|Variom Biotechnology AG||Europe|
|Siegfried Biologics GmbH||Europe|
|Orphatec Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CellAct Pharma GmbH, please visit www.cellact.eu. Company data is provided by Capital IQ. Please use this form to report any data issues.